Han-Min Jiang

1.8k total citations
9 papers, 253 citations indexed

About

Han-Min Jiang is a scholar working on Infectious Diseases, Hepatology and Epidemiology. According to data from OpenAlex, Han-Min Jiang has authored 9 papers receiving a total of 253 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Infectious Diseases, 5 papers in Hepatology and 4 papers in Epidemiology. Recurrent topics in Han-Min Jiang's work include Hepatitis Viruses Studies and Epidemiology (5 papers), Viral gastroenteritis research and epidemiology (4 papers) and Hepatitis B Virus Studies (4 papers). Han-Min Jiang is often cited by papers focused on Hepatitis Viruses Studies and Epidemiology (5 papers), Viral gastroenteritis research and epidemiology (4 papers) and Hepatitis B Virus Studies (4 papers). Han-Min Jiang collaborates with scholars based in China, Taiwan and United States. Han-Min Jiang's co-authors include Zhongze Wang, Jun Zhang, Ting Wu, Ningshao Xia, Fengcai Zhu, Shoujie Huang, Yijun Wang, Xing Ai, Mun‐Hon Ng and Qiang Yan and has published in prestigious journals such as Nature Communications, PLoS ONE and Vaccine.

In The Last Decade

Han-Min Jiang

9 papers receiving 249 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Han-Min Jiang China	6	179	120	86	23	16	9	253
Feiyan Long China	8	260 1.5×	211 1.8×	30 0.3×	29 1.3×	32 2.0×	11	322
Chenchen Yang China	11	340 1.9×	246 2.0×	42 0.5×	42 1.8×	35 2.2×	20	397
Djeneba Fofana France	14	44 0.2×	309 2.6×	111 1.3×	14 0.6×	10 0.6×	35	420
Mark Pronk Netherlands	6	147 0.8×	107 0.9×	150 1.7×	74 3.2×	6 0.4×	11	295
Randolph A. Moeckli United States	6	151 0.8×	120 1.0×	49 0.6×	24 1.0×	16 1.0×	6	260
Maliki Ankavay France	6	225 1.3×	160 1.3×	46 0.5×	10 0.4×	9 0.6×	10	250
Putu Prathiwi Primadharsini Japan	9	396 2.2×	327 2.7×	62 0.7×	10 0.4×	45 2.8×	24	455
Leonardo Nieto Spain	7	89 0.5×	145 1.2×	207 2.4×	2 0.1×	8 0.5×	10	238
Masoom Kassi Pakistan	8	27 0.2×	49 0.4×	184 2.1×	20 0.9×	3 0.2×	8	366
Évelyne Schvoerer France	10	175 1.0×	85 0.7×	168 2.0×	10 0.4×		15	226

Countries citing papers authored by Han-Min Jiang

Since Specialization

Citations

This map shows the geographic impact of Han-Min Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Han-Min Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Han-Min Jiang more than expected).

Fields of papers citing papers by Han-Min Jiang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Han-Min Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Han-Min Jiang. The network helps show where Han-Min Jiang may publish in the future.

Co-authorship network of co-authors of Han-Min Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Han-Min Jiang. A scholar is included among the top collaborators of Han-Min Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Han-Min Jiang. Han-Min Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Zhuang, Chunlan, Lu Chen, Han-Min Jiang, et al.. (2025). Effectiveness of a hepatitis E vaccine against medically-attended symptomatic infection in HBsAg-positive adults from a test-negative design study. Nature Communications. 16(1). 1699–1699. 1 indexed citations

2.

Chu, Kai, Xiaohui Liu, Qi Chen, et al.. (2025). A randomized phase I trial of intranasal SARS-CoV-2 vaccine dNS1-RBD in children aged 3–17 years. npj Vaccines. 10(1). 50–50. 2 indexed citations

3.

Zheng, Xiaoxiang, Chen Lin, Chunlan Zhuang, et al.. (2024). Active surveillance of hepatitis E: a 10-year epidemiological analysis in a city in eastern China. Emerging Microbes & Infections. 13(1). 2373315–2373315. 4 indexed citations

4.

Yue, Xiaoyu, Qi Zhong, Han-Min Jiang, et al.. (2018). Ni‐Catalyzed C−F Bond Functionalization of Unactivated Aryl Fluorides and Corresponding Coupling with Oxazoles. Advanced Synthesis & Catalysis. 360(8). 1639–1643. 15 indexed citations

5.

Wu, Ting, Yuemei Hu, Juan Li, et al.. (2015). Immunogenicity and safety of an E. coli-produced bivalent human papillomavirus (type 16 and 18) vaccine: A randomized controlled phase 2 clinical trial. Vaccine. 33(32). 3940–3946. 21 indexed citations

6.

Zhu, Fengcai, Shoujie Huang, Ting Wu, et al.. (2014). Epidemiology of Zoonotic Hepatitis E: A Community-Based Surveillance Study in a Rural Population in China. PLoS ONE. 9(1). e87154–e87154. 47 indexed citations

7.

Hu, Yuemei, Shoujie Huang, Kai Chu, et al.. (2013). Safety of anEscherichia coli-expressed bivalent human papillomavirus (types 16 and 18) L1 virus-like particle vaccine. Human Vaccines & Immunotherapeutics. 10(2). 469–475. 27 indexed citations

8.

Wu, Ting, Shoujie Huang, Fengcai Zhu, et al.. (2013). Immunogenicity and safety of hepatitis E vaccine in healthy hepatitis B surface antigen positive adults. Human Vaccines & Immunotherapeutics. 9(11). 2474–2479. 29 indexed citations

9.

Huang, Shoujie, Xuefeng Zhang, Han-Min Jiang, et al.. (2010). Profile of Acute Infectious Markers in Sporadic Hepatitis E. PLoS ONE. 5(10). e13560–e13560. 107 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact